Bone quality at the implant site after reconstruction of a local defect of the maxillary anterior ridge with chin bone or deproteinised cancellous bovine bone by Meijndert, L. et al.
  
 University of Groningen
Bone quality at the implant site after reconstruction of a local defect of the maxillary anterior
ridge with chin bone or deproteinised cancellous bovine bone
Meijndert, L.; Raghoebar, G.M.; Schüpbach, P.; Meijer, H.J.A.; Vissink, A.
Published in:
International Journal of Oral and Maxillofacial Surgery
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2005
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Meijndert, L., Raghoebar, G. M., Schüpbach, P., Meijer, H. J. A., & Vissink, A. (2005). Bone quality at the
implant site after reconstruction of a local defect of the maxillary anterior ridge with chin bone or
deproteinised cancellous bovine bone. International Journal of Oral and Maxillofacial Surgery, 34(8), 877-
884.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Bone quality at the implant site
after reconstruction of a local
defect of the maxillary anterior
ridge with chin bone or
deproteinised cancellous bovine
bone
L. Meijndert, G. M. Raghoebar, P. Schu¨pbach, H. J. A. Meijer, A. Vissink: Bone
quality at the implant site after reconstruction of a local defect of the maxillary
anterior ridge with chin bone or deproteinised cancellous bovine bone. Int. J. Oral
Maxillofac. Surg. 2005; 34: 877–884. # 2005 International Association of Oral and
Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
L. Meijndert1, G. M. Raghoebar1,
P. Schu¨pbach2, H. J. A. Meijer1,3,
A. Vissink1
1Department of Oral and Maxillofacial
Surgery and Maxillofacial Prosthetics,
University Medical Center Groningen and
University of Groningen, Groningen, The
Netherlands; 2University of Zu¨rich, Dental
Institute, Department of Oral Microbiology
and General Immunology, Zu¨rich,
Switzerland; 3Department of Oral Function,
Dental School, Faculty of Medical Sciences,
University Medical Center Groningen and
University of Groningen, Groningen, The
Netherlands
Abstract. The purpose of this study was to investigate the quality of bone at grafted
implant sites in the anterior maxilla. Grafting of these sites was necessary
because of insufficient bone volume in a buccopalatinal direction (width at the top
of the crest 1–3 mm).
Reconstruction was performed with chin bone (N = 5), chin bone and a resorbable
Bio-Gide1GBRmembrane (N = 5) or Bio-Oss1 spongiosa granules in combination
with aBio-Gide1GBRmembrane (N = 5). Biopsieswere taken prior to implantation,
i.e. 3months after graftingwith chin bone, and 6months after graftingwithBio-Oss1.
Evaluation was done by assessing the histological and histomorphometric
characteristics of full-length biopsies taken from the actual implant site.
Both areas with non-vital bone and areas with apposition of bone and remodelling
phenomena were observed in the chin bone group at the time of placement of the
implants. Similar results were observed at implant sites reconstructed with a
chin bone graft covered by a membrane. In the chin bone group without and with a
GBR membrane, the mean total bone volume (TBV) was 55.2  6.8% and
57.7  11.5%, respectively; the marrow connective tissue volume (MCTV) was
44.8  6.8% and 42.3  11.5%, respectively. Remnants of the resorbable GBR
membrane were not detected. In the Bio-Oss1 group, at implant placement some
newly formed bone was observed in the connective tissue surrounding the
Bio-Oss1 particles (mean TBV (newly formed bone) 17.6  14.5%), but most
particles were surrounded by connective tissue. No convincing signs of remodelling
were observed (mean remaining Bio-Oss1 volume 40.5  9.3%; mean MCTV
41.9  13.1%). No implants were lost during follow up (12 months).
At the time of placement of the implants the grafting material (either chin
bone or Bio-Oss1) is still not fully replaced by new vital bone. In case of Bio-Oss1,
most of the grafting material is even still present. Despite these differences,
the 1-year clinical results were very good and comparable between the various
grafting techniques applied.
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878 Meijndert et al.Reliable rehabilitation of the alveolar ridge axis of the implant12,22,34,35. This does not applied: chin bone (N = 5), chin bone in
1Table 1. Personal data and local status of all 15 patients treated for ridge enlargement
Patient Sex Age Site Increase in width at





1 F 37 11 4 Chin bone No
2 F 44 11 4 Chin bone No
3 M 24 21 3 Chin bone No
4 M 27 21 2 Chin bone No
5 F 38 12 2 Chin bone No
6 M 38 11 4 Chin bone Yes
7 F 37 21 3 Chin bone Yes
8 M 38 21 2 Chin bone Yes
9 F 19 11 3 Chin bone Yes
10 F 37 21 5 Chin bone Yes
11 M 51 14 3 Bio-Oss Yes
12 F 29 11 2 Bio-Oss Yes
13 F 27 11 3 Bio-Oss Yes
14 M 50 12 2 Bio-Oss Yes
15 M 26 11 2 Bio-Oss Yeswith endosseous implants requires proper
quality and quantity of alveolar bone at the
implant site in order to achieve a good long-
term prognosis3,11,33. There is a diversity of
surgical techniques and augmentation
materials available for improving ridge
conditions that meet these require-
ments4,13,14,16,17,24,25,30,32. Such techniques
include the use of grafting materials, either
alone or in combination with barrier mem-
branes5,6,15. The most widely applied graft-
ing material is autogenous bone, which has
proven its value as grafting material for
reconstruction of bony defects13,25,30.
Autogenous bone is harvested from both
intra-oral and extra-oral sites. Autogenous
bone is considered the ‘‘gold standard’’,
but harvesting of autogenous bone requires
surgery at a donor site. This among others
results in increased morbidity, operation
time and costs18,25,31. These considerations
have led to a search for bone substitutes that
are biocompatible, non-infectious, non-
antigenic and resorbable.
Reports on ridge augmentation are
merely clinical studies on implant survi-
val as a function of the augmentation
material used and as a function of
time8,36,37. These clinical data are not
indicative for the quality of the bone at
the implantation site in case of recon-
struction of local defects3. Histological
analysis of the tissue at the implant site is
needed focusing on a detailed character-
isation of bone healing and remodelling.
Several studies are available focusing on
descriptive histology and histomorpho-
metric analysis of autologous bone and
bone substitutes. Resorption of autolo-
gous bone grafts (up to 56% of cortical
bone grafts in 4 months) is reported in
both animal and human studies3,23,27,37.
Conflicting results have been reported
regarding the long-term behaviour of
Bio-Oss1; some authors have described
signs of resorption while others have
reported a lack of break-
down1,2,14,19,23,28,34,35,38. Histomorpho-
metric analysis of biopsies taken 4–6
months after augmentation show a total
bone volume (TBV) in autologous bone
augmented sites of 37–47%1,3,12. In
Bio-Oss1 augmented sites a TBV of
14–42% newly formed bone is repor-
ted after 6 months and a proportion
of residual Bio-Oss1 material of 13–
30%1,3,12,38.
A major drawback of most of the
reports available in literature to date is
that the biopsies taken for analysis are
not derived from the actual implant site.
The biopsies are harvested next to the
implant site or perpendicular to the longprovide exact information on the quality of
bone at the actual implant site. The biopsy
can show the presence of autogenous bone
or a substitute at the biopsy spot while the
opposite might be true for the implantation
spot. Therefore, the aim of this studywas to
investigate the quality of the bone at the
implant site by assessing histological and
histomorphometric characteristics of biop-
sies taken from the actual implant site and
over the full length of the implant section in
the anterior maxilla just prior to implanta-
tion. Additionally, clinical assessments
were performed to compare the histologi-
cal and histomorphometric findings with
the clinical characteristics of the peri-
implant gingiva.Materials and methods
Fifteen patients, seven men and eight
women with a mean age of 32.9 years
(range 18–50 years), received an augmen-
tation procedure for reconstruction of
local defect of the anterior maxilla to
provide a basis for reliable insertion of
endosseous dental implants. All patients
were non-smoking, partially edentulous
and presented with a single tooth gap
(Table 1). In all cases, the implantation
site had to be reconstructed because of
insufficient bone volume in a buccopalat-
inal direction.
The defects were located in the ‘‘aes-
thetic zone’’ of the anterior maxilla. The
pre-surgical evaluation disclosed an anat-
omy of the local bone responding to a class
IV and V according to CAWOOD &
HOWELL7, which did not allow the place-
ment of an endosseous implant with suffi-
cient initial stability. To reconstruct these
defects, three treatment modalities werecombination with a Bio-Gide GBR-
membrane (Geistlich, Wolhusen, Switzer-
land; N = 5) and Bio-Oss1 spongiosa
granules (0.25–1.0 mm, Geistlich, Wolhu-
sen, Switzerland) in combin ation with
a Bio-Gide1 GBR membrane (N = 5)
(Fig. 1). A computer software program
randomly placed the participating patients
into these groups. Informed consent was
obtained from all patients.
Surgical procedures
All patients were treated under local
anaesthesia. Antibiotic prophylaxis was
given for 72 h (amoxycillin 500 mg + cla-
vulanic acid 125 mg (Augmentin1,
SmithKline Beecham, Zeist, The Nether-
lands), 1 h preoperatively and every 8 h
postoperatively).
First a buccal pedunculated and to the
buccal side reflected mucoperiosteal full-
thickness flap was raised. From the top of
the crest the incisions diverged to the
buccolabial fold and were placed in such
a way that the mucoperiosteal flap is on
each side 5 mm wider then the area to be
augmented. The interdental papillae were
included in the flap. The extension of the
incision to palatal is 5 mm from the top
of the crest.
After mucoperiosteal reflection the oro-
facial bone width at the implant site was
measured to the nearest quarter of a milli-
metre using a calliper. The width ranged
from 1 to 3 mm. The cortical bone on the
receptor site was perforated with a small
round bur in order to create a bleeding
bone surface and to open the cancellous
bone.
Monocortical chin bone grafts (N = 10
patients) were harvested using a bur and
chisels and fixed on the perforated recep-
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Fig. 1. Design of the study.tor site (cortical side to the buccal) with a
1.5 mm titanium screw (Martin, Tutlin-
gen, Germany)30. Particulated chin bone
was placed around the fixed block graft. In
five patients, the chin bone graft was
covered by a Bio-Gide1 GBR membrane.
The membrane was styled with a 3 mm
extension over the bone margins of the
defect and fixed with sutures (Vicryl 4-0,
Ethicon, Johnson & Johnson, Amersfoort,
The Netherlands).
Bio-Oss1 granules (N = 5 patients)
were mixed with blood derived from the
operation site and placed on the perforatedcortical bone of the receptor site. A Bio-
Gide1 GBR membrane was applied to
cover the grafts. The membrane was styled
with a 3 mm extension over the bone
margins of the defect and fixed with
sutures (Vicryl 4-0).
Three months after augmentation of the
anterior defect in the maxilla with chin
bone or 6 months after augmentation with
Bio-Oss1, the implants were placed.
Again, the orofacial bone width at the
implant site was measured to the nearest
quarter of a millimetre. The screws used to
fix the bonegrafts were removed. Subse-quently a biopsy was taken from the
implant site using a trephine bur (Ø
2.0 mm). Finally, after widening the
biopsy spot to the required dimension
using standard burs, ITI-EstheticPlus dental
implants (Institut Straumann AG,Walden-
burg, Switzerland) were placed. The
implants were uncovered 6 months after
placement.
A single operator (GMR) performed all
surgical procedures.
At the day of uncovering the implants a
temporary crown was placed, followed by
the placement of the final crown 1 month
later.Clinical assessments
Clinical assessments were objectively per-
formed at 1 (T0) and 12 months (T12) after
placement of the final crown using the
Gingiva Index (GI), pocket probing depth
(PPD), and measuring the width of the
attached mucosa (WAM) according to
established methods in the literature (see
below). Additionally, the level of the
marginal buccal gingiva (MBGL)wasmea-
sured. All clinical assessments were per-
formed by a single investigator (L.M.)
(Fig. 1).1. LO¨E & SILNESS Gingiva Index20,21
0 = normal gingiva/mucosa around the
tooth;
1 = mild inflammation; slight change
in colour, slight oedema;
2 = moderate inflammation; redness,
oedema and glazing;
3 = severe inflammation; marked red-
ness and oedema, ulceration.2. Pocket probing depth29
Using a Merrit-B perioprobe the
depth of the pocket on the buccal side
of the implant-supported crown was
measured. The distance between the
marginal border of the gingiva and
the tip of the pocket probe was scored
as the PPD.3. Width of attached mucosa9
The width of the attached mucosa
buccal of the implant-supported crown
was measured using the ‘‘Attached
mucosa index’’
0 = no keratinised epithelium is avail-
able;
1 = 1 mm or less keratinised epithe-
lium;
2 = 1 or 2 mm keratinised epithelium;
3 = more than 2 mm keratinised epithe-
lium.4. Level of the buccal marginal gingiva
The level of the buccal marginal
gingiva was scored by measuring the
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Fig. 2. The level of the buccal marginal gingiva was scored in the midline of the crown by
measuring the distance between the marginal border of the buccal gingiva and the incisal edge of
the implant supported crown.distance between the marginal border
of the buccal gingiva and the incisal
edge of the implant supported crown
(Fig. 2).
Histology
Biopsies were taken using a 2.0 mm tre-
phine bur resulting in specimen with a
core diameter of 1.7 mm. The biopsies
were taken at the same location as the
‘‘implant-to-be-placed’’, at a similar
angulation as the implant and up to a depth
of 12 mm. By choosing a trephine bur with
a diameter of 2.0 mm, the procedure of
taking the biopsy did not interfere with the
positioning of the implant (diameter
4.1 mm). Bio-Oss1 specimens were easier
to remove from the trephine than chin
bone biopsies. All specimens could be
removed in toto for evaluation.
The specimens were fixed in buffered
formalin solution (4%). For histologic
processing the specimens were washed
in 0.185 M sodium cacodylate buffer
for 2 h, dehydrated in ethanol and
embedded in light-cured composite mate-
rial (Technovit 7200 VLC, Kulzer, Frier-
ichsdorf, Germany). Undemineralised
longitudinal sections were cut from the
central parts of the biopsies and ground to
a thickness of 30 mm according to the
method of DONATH & BREUNER10. Subse-
quently, the sections were surface stained
with Toluidine blue/Pyronine G and eval-
uated histologically and histometrically.Histological assessments
The biopsies were evaluated with regard to
the vitality of the bone (presence of osteo-
cytes in the osteocyte lacunae), signs ofremodelling (presence of osteoblast,
osteoı¨d and osteoclasts) and maturity of
the bone (woven bone versus lamellar
bone). Quantitative evaluation was per-
formed with the aid of a light microscope
and the use of ImageAccess (Imagic,
Glattbrugg, Switzerland) software. As a
region of interest (ROI) it was decided to
analyse the superior two-thirds of the spe-
cimen in order to ensure to predominantly
analyse grafted material.
For the bone histomorphometric ana-
lysis the following values were mea-
sured:1. The total bone volume (TBV): the per-
centage of the section consisting of
bone tissue.2. The marrow connective tissue volume
(MCTV): the percentage of the section
consisting of marrow and connective
tissue.3. The remaining Bio-Oss1 volume
(RBOV): the percentage of the section
consisting of Bio-Oss1 material.4. The total mineralised mass (TMM): the
percentage of the section consisting of
mineralised material (augmentation
material (chin bone/Bio-Oss1)/newly
formed bone)All histological assessments were per-
formed by a single investigator (PS) not
being involved in patient treatment.Results
None of the 15 patients complained of
significant pain either at the donor site
or at the reconstructed local defect site
in the maxilla. Similarly, no objective
signs of infection were observed. Therewas sufficient bone to place implants with
a length of 12 mm in all cases. The width
of the orofacial bone at the implant site
gained 2–5 mm (Table 1). Clinically,
when compared to the implant sites recon-
structed with chin bone grafts, the bone at
the implant site reconstructed with Bio-
Oss1 was not as compact as the bone at
the sites reconstructed with chin bone.
Nevertheless, the initial stability of the
implants was good in all cases. No
implants were lost during the follow up.Clinical assessments
At T0, five implants showed mild inflam-
mation (Gingiva Index Score 1), while the
other 10 implants had normal peri-implant
tissue (Score 0). Twelve months after
placement of the final crown (T12), one
implant showed mild inflammation and 14
implants had a normal peri-implant gin-
giva/mucosa. The mean PPD on the buccal
side of the implant-supported crown was
3.0  1.4 mm at T0 and 3.3  1.8 mm at
T12. All cases showed an attached mucosa
of 2 mm or more around the implant sup-
ported crowns. The distance between the
marginal border of the buccal gingiva and
the incisal edge of the implant supported
crown decreased with 0.24  1.04 mm
between T0 and T12.Histological assessments
Mineralised material with a trabecular
bone pattern was found in all biopsies
derived from the augmented areas with
some trabecular bone present in the
biopsies derived from areas grafted with
Bio-Oss1, and both trabecular and com-
pact bone from areas grafted with chin
bone. In all groups, a mixture of mature
and immature bone was present.
In specimen taken from areas grafted
with chin bone, 3 months after grafting,
the grafted particles were (partly) sur-
rounded by layers of newly formed bone
(Fig. 3A). All 10 biopsies from areas
grafted with chin bone contained such
areas. Part of these particles showed
empty lacunae suggesting that these
particles were non-vital, while other
particles or parts of them clearly
showed lacunae occupied by osteocytes
(Fig. 3B). All chin bone biopsies showed
signs of remodelling as shown by the
presence of osteoblasts, apposition of
osteoı¨d and resorption lacunae occupied
with multinuclear osteoclasts. Apposi-
tion of bone and remodelling phenomena
were observed on both non-vital and
vital chin bone particles. No differences
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Fig. 3. (A) Section of a biopsy specimen after augmentation with chin bone. The biopsy is
composed of larger and smaller cortical bone particles. Newly formed bone is clearly visible. (B)
Detail showing vital, newly formed bone. In most lacunae osteocytes are present.were observed between biopsies derived
from grafted areas that were covered by a
resorbable membrane or not. Remnants
of the Bio-Gide1 membrane were not
detected.
In specimens taken from the Bio-Oss1
augmented sites, 6 months after grafting,
some newly formed bone was present in
the connective tissue surrounding the Bio-
Oss1 particles, but most of the particles
were surrounded by connective tissue
(Fig. 4A and B). Bio-Oss1 particles were
present in four out of five biopsies. In the
biopsies with Bio-Oss1 particles neither
signs of inflammation nor signs of foreign
body reaction were seen around the Bio-
Oss1 particles. A minority of the particles
was in contact with newly formed vital
bone with lacunae occupied by osteocytes.
Thus, at least locally, there seems to be
some bone-apposition on the surface of the
Bio-Oss1 particles (Fig. 4C), but this is
not a general phenomenon 6 months after
grafting. Although some scalloping of
the surface of the Bio-Oss1 particles
was noted, no osteoclasts were found in
the specimen. Thus, convincing evidence
of resorption of the Bio-Oss1 particles
or signs of remodelling could not be
demonstrated in our samples. Again, rem-
nants of the Bio-Gide1 membrane were
not detected.Histomorphometry
The mean TBV was in the Bio-Oss1
group significantly lower when compared
to areas grafted with chin bone (p < 0.01,
t-test), but the mean TMM was compar-
able between the three groups. TheMCTV
in the Bio-Oss1 group was comparable to
the MCTV of the chin bone groups. The
RBOV mounted for the remaining part
(Table 2).Discussion
The search for the ideal augmentation
material still goes on. Although autologous
bone is generally well accepted by most of
the patients, autologous bone always
involves donor site surgery and thus donor
site morbidity18,31. Also when mixing allo-
graft material with autologous bone, as
often advocated, there still might be a need
of an extra donor site in case not sufficient
bone can be harvested near the implant
site38. The results of this study indicate
that also buccal grafting of a local defect in
the aesthetic zone of the maxillary alveolar
ridge with Bio-Oss1might provide a basis
for reliable placement of implants.
The ideal biopsy for histological eva-
luation of the bone at the implant site
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Fig. 4. (A) Section of a biopsy specimen after augmentation with Bio-Oss1. The Bio-Oss1
particles are surrounded by connective tissue. Locally vital, newly formed bone is observed. (B)
Detail showing the relation between Bio-Oss1 particles, connective tissue and newly formed
bone. (C) Detail showing newly formed bone in close contact with a Bio-Oss1 particle
suggesting apposition of bone on the surface of Bio-Oss1 particles. The lacunae in the newly
formed bone contain osteocytes.should be taken from the actual implant
site and has a diameter and length equal to
the implant. It is possible, as shown in this
study, to equal the actual implant length
and the implant site, but by equalling the
diameter of the implant-to-be-placed in
the biopsy there is an inherent risk of
adversely affecting the initial stability of
the implant. For this reason we used a
trephine with a diameter slightly less than
the diameter of the implant. Even this
method includes to a certain extent the
deficits of methods harvesting biopsies
next to the implant site or perpendicular
to the long axis of the implant22,34,35 as in
one of our biopsies no grafting material
was detected.
The biopsy in which no grafting mate-
rial (Bio-Oss1) was present most likely
was taken from pre-existing autologous
alveolar bone just palatal from the aug-
mented area not touching the augmenta-
tion tissue. This might give rise to the
assumption that in this patient augmenta-
tion of the defect was not necessary. It is
still possible, however, that after taking
the biopsy (using a 2.0 mm trephine bur)
the augmentation material was exposed to
the drill hole side after using the final drill
for the implant surgery (diameter
3.8 mm). Alternatively, the applied histo-
logical processing technique (only the
central part of the biopsy) might be
responsible for the absence of augmenta-
tion material in the biopsy. But even if the
implant is not in direct contact with the
grafting material, it is thought that aug-
mentation is necessary in such cases.
Because of a good long-term prognosis,
bone grafting is not only applied for good
initial implant stability, but also to provide
the buccal bone plate a minimum thick-
ness of 2 mm and to shape the buccal
aspect of the jaw. This to try to prevent
resorption of a thin buccal bone plate and
to support the buccal gingiva for an opti-
mal aesthetic result of the peri-implant
soft tissues. Furthermore, this observation
stresses the purpose of our study, viz. to
investigate the quality of the bone as close
to the actual implant site as possible.
When drawing conclusions from biopsies
taken, e.g. next to the implant site or
perpendicular to the long axis of the
implant22,34,35 there is an inherent risk
of drawing these conclusions from a mis-
concept because the bone quality at the
actual implant site might be different from
the bone in the surrounding area.
In all biopsies with Bio-Oss1 granules
present, these granules maintained their
volume as well showed some osteocon-
ductive properties. The granules were
embedded in areas with vital bone, but,
Bone quality at a reconstructed implant site 883
Table 2. Total bone volume (TBV), marrow connective tissue volume (MCTV), the remaining Bio-Oss1 volume (RBOV) and the total
mineralised mass (TMM)
Mean TBV (%) Mean MCTV (%) Mean RBOV (%) Mean TMM (%)
Chin bone without GBR membrane 55.2  6.8 44.8  6.8 – 55.2  6.8
Chin bone with GBR membrane 57.7  11.5 42.3  11.5 – 57.7  11.5
Bio-Oss1 with GBR membrane 17.6  14.5 41.9  13.1 40.5  9.3 58.1  13.8as no convincing signs of resorption were
observed, 6 months after grafting the Bio-
Oss1 material was still in place. On the
surface of the Bio-Oss1 particles some
scalloping was observed, but presence of
osteoclasts could not been shown. There-
fore, it is not possible to state whether this
scalloping is due to post-grafting osteo-
clastic activity. Also YILDIRIM et al.38
found no osteoclastic activity after 6
months in humans. Other authors suggest
a slow but predictable resorption of Bio-
Oss1 in humans1,12,34,35. This probably
will occur, but only on the long term as
PIATELLI et al.28 observed the presence of
osteoclasts in the process of resorbing the
Bio-Oss1 particles and formation of
neighbouring newly formed bone in biop-
sies retrieved after 18 months and 4 years.
These human data are in contrast to animal
data reporting that Bio-Oss1 appears to be
progressively resorbed during a 3–7-
month period and became integrated and
subsequently replaced by newly formed
bone2,14,19,23.
In all areas grafted with chin bone non-
vital bone was still present 3 months after
augmentation. This is in full agreement
with the study of ZERBO et al.40 reporting
that non-vital bone is replaced by new
vital bone in approximately 7 months.
Notwithstanding the fact that the heal-
ing time in the Bio-Oss1 group was dou-
ble of that of the chin bone groups, 6
months after augmentation the majority
of the Bio-Oss1 granules was not replaced
by bone. The RBOV found in this study is
comparable to the RBOV reported in the
literature12,26,28,38,39. Obviously, the Bio-
Oss1 group can be expected to render
smaller values for the TBV than chin bone
groups due to the fact that part of the
defect space is filled with Bio-Oss1 par-
ticles. When the RBOV is added to the
calculation, similar values for the TMM
were obtained for the Bio-Oss1 group and
the chin bone groups. Despite the rela-
tively low osteoinductive capacity of sym-
physial bone compared to other
autologous bone grafts, it is still superior
to Bio-Oss1 considering the difference in
healing time (3 months) needed to achieve
the same results.
It was noted that the initial stability of
the implants was good in all cases
although the bone at the implant sitesreconstructed with Bio-Oss1 clinically
was not as compact as the bone at sites
reconstructed with chin bone. A possible
explanation for this is that in the Bio-Oss1
cases the apical part of the implants could
have been inserted in pre-existing alveolar
bone, in which case the support of the pre-
existing alveolar bone is responsible for
the good initial stability of the implants
rather than the Bio-Oss1 augmentation
material. As it takes more than 6 months
for the implants to be loaded (abutment
connection is performed 6 months after
implant placement) further ingrowth of
bone and suggested remodelling of the
grafting material probably will have
occurred thus allowing for loading of
the implants.
From this study, it is concluded that at
the time of placement of the implants the
grafting material is still not fully replaced
by new vital bone. In case of Bio-Oss1,
most of the grafting material is even still
present. Despite these differences, the 1-
year clinical results were very good and
comparable between the various grafting
techniques applied.
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